Show simple item record

dc.contributor.authorRaschpichler, Gabriele
dc.contributor.authorRaupach-Rosin, Heike
dc.contributor.authorAkmatov, Manas K
dc.contributor.authorCastell, Stefanie
dc.contributor.authorRübsamen, Nicole
dc.contributor.authorFeier, Birgit
dc.contributor.authorSzkopek, Sebastian
dc.contributor.authorBautsch, Wilfried
dc.contributor.authorMikolajczyk, Rafael
dc.contributor.authorKarch, André
dc.date.accessioned2020-11-10T13:24:04Z
dc.date.available2020-11-10T13:24:04Z
dc.date.issued2020-10-22
dc.identifier.citationSci Rep. 2020 Oct 22;10(1):17998. doi: 10.1038/s41598-020-75094-6.en_US
dc.identifier.pmid33093607
dc.identifier.doi10.1038/s41598-020-75094-6
dc.identifier.urihttp://hdl.handle.net/10033/622569
dc.description.abstractIn countries with low endemic Methicillin-resistant Staphylococcus aureus (MRSA) prevalence, identification of risk groups at hospital admission is considered more cost-effective than universal MRSA screening. Predictive statistical models support the selection of suitable stratification factors for effective screening programs. Currently, there are no universal guidelines in Germany for MRSA screening. Instead, a list of criteria is available from the Commission for Hospital Hygiene and Infection Prevention (KRINKO) based on which local strategies should be adopted. We developed and externally validated a model for individual prediction of MRSA carriage at hospital admission in the region of Southeast Lower Saxony based on two prospective studies with universal screening in Braunschweig (n = 2065) and Wolfsburg (n = 461). Logistic regression was used for model development. The final model (simplified to an unweighted score) included history of MRSA carriage, care dependency and cancer treatment. In the external validation dataset, the score showed a sensitivity of 78.4% (95% CI: 64.7-88.7%), and a specificity of 70.3% (95% CI: 65.0-75.2%). Of all admitted patients, 25.4% had to be screened if the score was applied. A model based on KRINKO criteria showed similar sensitivity but lower specificity, leading to a considerably higher proportion of patients to be screened (49.5%).en_US
dc.language.isoenen_US
dc.publisherNature publishing group (NPG)en_US
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleDevelopment and external validation of a clinical prediction model for MRSA carriage at hospital admission in Southeast Lower Saxony, Germany.en_US
dc.typeArticleen_US
dc.identifier.eissn2045-2322
dc.contributor.departmentHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.en_US
dc.identifier.journalScientific reportsen_US
dc.source.volume10
dc.source.issue1
dc.source.beginpage17998
dc.source.endpage
refterms.dateFOA2020-11-10T13:24:04Z
dc.source.journaltitleScientific reports
dc.source.countryEngland


Files in this item

Thumbnail
Name:
Raschpichler et al.pdf
Size:
950.1Kb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International